Q3 2015 13F Holders as of 9/30/2015
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
192M
-
Number of holders
-
385
-
Total 13F shares, excl. options
-
159M
-
Shares change
-
+1.04M
-
Total reported value, excl. options
-
$16.8B
-
Value change
-
+$90.3M
-
Put/Call ratio
-
0.98
-
Number of buys
-
192
-
Number of sells
-
-188
-
Price
-
$105.32
Significant Holders of BIOMARIN PHARMACEUTICAL INC - COM (BMRN) as of Q3 2015
474 filings reported holding BMRN - BIOMARIN PHARMACEUTICAL INC - COM as of Q3 2015.
BIOMARIN PHARMACEUTICAL INC - COM (BMRN) has 385 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 159M shares
of 192M outstanding shares and own 83.14% of the company stock.
Largest 10 shareholders include Capital Research Global Investors (18.9M shares), FMR LLC (16.6M shares), SANDS CAPITAL MANAGEMENT, LLC (11.4M shares), VANGUARD GROUP INC (10.8M shares), PRICE T ROWE ASSOCIATES INC /MD/ (7.54M shares), PRIMECAP MANAGEMENT CO/CA/ (7.37M shares), JPMORGAN CHASE & CO (5.16M shares), JENNISON ASSOCIATES LLC (4.95M shares), BAKER BROS. ADVISORS LP (4.08M shares), and BlackRock Fund Advisors (3.84M shares).
This table shows the top 385 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.